» Articles » PMID: 31963112

Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study

Abstract

This study describes medication use by women up to 3 months postpartum and evaluates the association between medication use by women who were still breastfeeding at 3 months postpartum and weaning at 6 and 12 months. Population-based cohort, including women who breastfed ( = 3988). Medications were classified according to Hale's lactation risk categories and Brazilian Ministry of Health criteria. Duration of breastfeeding was analysed using Cox regression models and Kaplan-Meier curves, including only women who were still breastfeeding at three months postpartum. Medication use with some risk for lactation was frequent (79.6% regarding Hale's risk categories and 12.3% regarding Brazilian Ministry of Health criteria). We did not find statistically significant differences for weaning at 6 or 12 months between the group who did not use medication or used only compatible medications and the group who used medications with some risk for lactation, according to both criteria. Our study found no association between weaning rates across the different breastfeeding safety categories of medications in women who were still breastfeeding at three months postpartum. Therefore, women who took medications and stopped breastfeeding in the first three months postpartum because of adverse side-effects associated with medications could not be addressed in this analysis.

Citing Articles

The use of prescription medications and non-prescription medications during lactation in a prospective Canadian cohort study.

Soliman Y, Yakandawala U, Leong C, Garlock E, Brinkman F, Winsor G Int Breastfeed J. 2024; 19(1):23.

PMID: 38589955 PMC: 11000278. DOI: 10.1186/s13006-024-00628-x.


Medicines postpartum in Sweden and coverage in Janusmed Breastfeeding.

Asplund A, Skold P, Lind L, Cesta C, Dahl M, Jonsson E Eur J Clin Pharmacol. 2023; 79(9):1261-1269.

PMID: 37452835 PMC: 10427528. DOI: 10.1007/s00228-023-03528-x.


Medication Intake as a Factor for Non-Initiation and Cessation of Breastfeeding: A Prospective Cohort Study in Greece during the COVID-19 Pandemic.

Tigka M, Metallinou D, Nanou C, Iliodromiti Z, Gryparis A, Lykeridou K Children (Basel). 2023; 10(3).

PMID: 36980144 PMC: 10047701. DOI: 10.3390/children10030586.


Shared decision-making about medication intake during lactation: A prospective longitudinal study in Greece.

Tigka M, Metallinou D, Pardali L, Lykeridou K Eur J Midwifery. 2022; 6:48.

PMID: 35974713 PMC: 9340817. DOI: 10.18332/ejm/149830.


Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries.

Ceulemans M, Foulon V, Panchaud A, Winterfeld U, Pomar L, Lambelet V Int J Environ Res Public Health. 2022; 19(3).

PMID: 35162405 PMC: 8835534. DOI: 10.3390/ijerph19031389.


References
1.
Rollins N, Bhandari N, Hajeebhoy N, Horton S, Lutter C, Martines J . Why invest, and what it will take to improve breastfeeding practices?. Lancet. 2016; 387(10017):491-504. DOI: 10.1016/S0140-6736(15)01044-2. View

2.
Figueiredo B, Canario C, Field T . Breastfeeding is negatively affected by prenatal depression and reduces postpartum depression. Psychol Med. 2013; 44(5):927-36. DOI: 10.1017/S0033291713001530. View

3.
McDonald K, Amir L, Davey M . Maternal bodies and medicines: a commentary on risk and decision-making of pregnant and breastfeeding women and health professionals. BMC Public Health. 2011; 11 Suppl 5:S5. PMC: 3247028. DOI: 10.1186/1471-2458-11-S5-S5. View

4.
Horta B, Loret de Mola C, Victora C . Breastfeeding and intelligence: a systematic review and meta-analysis. Acta Paediatr. 2015; 104(467):14-9. DOI: 10.1111/apa.13139. View

5.
Horta B, Loret de Mola C, Victora C . Long-term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure and type 2 diabetes: a systematic review and meta-analysis. Acta Paediatr. 2015; 104(467):30-7. DOI: 10.1111/apa.13133. View